Michelle Renee Griffin's Net Worth
$3.29 Million
Who is Michelle Renee Griffin?
Michelle Renee Griffin has an estimated net worth of $3.29 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, PHASERX, INC., Trubion Pharmaceuticals, Inc, CHINOOK THERAPEUTICS, INC., HTG MOLECULAR DIAGNOSTICS, INC, ONCOGENEX PHARMACEUTICALS, INC., Acer Therapeutics Inc., DENDREON CORP, and CORIXA CORP.
SEC CIK
Michelle Renee Griffin's CIK is 0001229765
Past Insider Trading and Trends
2021 was Michelle Renee Griffin's most active year for acquiring shares with 15 total transactions. Michelle Renee Griffin's most active month to acquire stocks was the month of April. 2005 was Michelle Renee Griffin's most active year for disposing of shares, totalling 23 transactions. Michelle Renee Griffin's most active month to dispose stocks was the month of June. 2005 saw Michelle Renee Griffin paying a total of $639,499.26 for 364,974 shares, this is the most they've acquired in one year. In 2005 Michelle Renee Griffin cashed out on 729,591 shares for a total of $932,214.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $3.585
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +151.88% | 31.33K |
—
|
—
| 51.95K |
Mar 4
| |||
Form 4
| -10.19% | -2.34K |
$8.49 | -$19,878.13 | 20.63K |
Mar 27
| |||
Form 4
| +180.34% | 14.78K |
—
|
—
| 22.97K |
Mar 6
| |||
Form 4
| +444.75% | 6.69K |
—
|
—
| 8.19K |
Jan 26
| |||
Form 4
|
—
|
0
|
$21.40 | -$405,715.20 | 1.5K |
Scheduled
|
Aug 27
| ||
Form 4
|
—
|
0
|
$22.30 | -$72,500.00 | 1.5K |
Scheduled
|
Jul 14
| ||
Form 4
|
—
|
0
|
$23.90 | -$128,800.00 | 1.5K |
Scheduled
|
Jun 17
| ||
Form 4
|
—
|
0
|
$23.18 | -$76,900.00 | 1.5K |
Scheduled
|
Jun 14
| ||
Form 4
|
—
|
0
|
$21.40 | -$68,000.00 | 1.5K |
Scheduled
|
May 18
| ||
Form 4
|
—
|
0
|
$25.60 | -$160,245.00 | 1.5K |
Scheduled
|
Apr 14
| ||
Form 4
|
—
|
0
|
$25.43 | -$211,563.48 | 1.5K |
Scheduled
|
Mar 15 - Mar 16
| ||
Form 4
|
∞
| 1.5K |
$36.44 | -$343,680.00 | 1.5K |
Scheduled
|
Feb 14 - Feb 16
| ||
Form 4
|
—
|
0
|
$36.84 | -$348,452.94 |
0
|
Scheduled
|
Jan 14
| ||
Form 4
|
—
|
0
|
$33.32 | -$306,240.20 |
0
|
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
$27.74 | -$239,334.67 |
0
|
Scheduled
|
Nov 16
| ||
Form 4
|
—
|
0
|
$30.32 | -$540,497.09 |
0
|
Scheduled
|
Oct 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PHASERX, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trubion Pharmaceuticals, Inc No price found
Senior V.P. and C.O.O.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHINOOK THERAPEUTICS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.30K |
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
∞
| 3.3K |
—
|
—
| 3.3K |
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ) Snapshot price: $0.0013
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||